Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-243117 is an effective selective LCK inhibitor with good cell activity (IC(50)=1.1 microM) and inhibition of T cell proliferation, which has great potential for therapeutic immunosuppression and the treatment of diseases such as rheumatoid arthritis and asthma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | BMS-243117 is an effective selective LCK inhibitor with good cell activity (IC(50)=1.1 microM) and inhibition of T cell proliferation, which has great potential for therapeutic immunosuppression and the treatment of diseases such as rheumatoid arthritis and asthma. |
Synonyms | UNII-MBE6KWV0QI, CHEMBL67237, MBE6KWV0QI |
Molecular Weight | 416.92 |
Formula | C20H21ClN4O2S |
CAS No. | 225521-80-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-243117 225521-80-2 CHEMBL 67237 CHEMBL-67237 BMS 243117 UNII-MBE6KWV0QI CHEMBL67237 BMS243117 MBE6KWV0QI inhibitor inhibit